Research Compliance

The Office of Research Compliance (RSCP), a unit of the Office of Research & Innovation, is responsible for ensuring institutional compliance with federal and state regulatory requirements and University policies pertaining to sponsored and unsponsored research. RSCP staff will be happy to answer any questions you have pertaining to the regulatory oversight of research.

 

Support Areas
 

All University research, teaching, and training activities involving animals covered under either the Public Health Service Policy on Humane Care and Use of Laboratory Animals (“PHS Policy”) or the USDA Animal Welfare Act and Regulations (AWAR) are subject to review and approval by the Institutional Animal Care and Use Committee (IACUC), irrespective of funding source. Institutional policy (701.0, Animal Care and Use) precludes the use of dogs, cats, and nonhuman primates in University research. More information can be found on the Animal Care and Use webpage.

University research, teaching, and business activities involving recombinant and/or synthetic nucleic acid materials (rDNA); microorganisms; biological toxins; bloodborne pathogens; human and nonhuman primate materials; and transgenic plants and animals, are subject to review and approval by the Institutional Biosafety Committee (IBC). RSCP also works closely with the Office of Environmental Health & Safety (EHS) for ongoing oversight of activities subject to IBC review and approval. More information can be found on the Biological Safety webpage.

Any item that is sent from the United States to a foreign destination is an export. The release of controlled items/information to a foreign person within the boundaries of the United States is a “deemed export.” The release (export) of certain goods, services, technology, data, and technical information is strictly controlled by Federal regulations. Prior to collaborating with, visiting, or sharing equipment, technical data and information, etc. with foreign persons in the United States or abroad, personnel must determine whether government authorization is needed for those activities. More information can be found on the Export Control webpage.

Research is defined as a systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge. A human subject is a living person about whom an investigator conducting research obtains either (1) data through intervention or interaction with the individual; or (2) identifiable private information. Activities meeting both these definitions is considered Human Subjects Research (HSR) and is subject to review and approval by the Institutional Review Board (IRB). All such activities must be approved prior to project initiation; projects will not be approved retroactively. Research activities may be approved for up to one year at a time. More information can be found on the Human Subjects Research webpage.

The University of Arkansas places the highest value on research integrity. The protection of the rights and interests of research participants, the maintenance of the public trust, and the freedom to disseminate ideas through the publication of research results are critical to the institutional mission and values. The Office of Research Compliance reviews all COI/COC submissions and all allegations of research misconduct. More information can be found on the Responsible Conduct of Research webpage.

Contact the Director for assistance with any of these.

 

RSCP Staff

 

Join our mailing list

Please submit the following form to subscribe to the latest updates and information from our office.

You can unsubscribe from receiving it anytime.

* indicates a required field




 

 

  RESEARCH COMPLIANCE ALERT

UPCOMING MEETINGS

IACUC Meeting: Friday, June 12 at 9 a.m. via Microsoft Teams.

IBC Meeting: Thursday, June 11 at 2:15 p.m. See IBC Coordinator for virtual meeting details.

IRB Meeting:Please contact the IRB Coordinator for details on the next meeting.

 

Committee meetings will be conducted via webinar or teleconference until further notice. Protocol review will be on a case-by-case basis until regular campus operations resume.